News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2024
August 2024
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Chiara Mercinelli: An honor to present Nure Combo trial at ASCO GU24
Photo taken from Chiara Mercinelli/X
Jan 30, 2024, 15:45

Chiara Mercinelli: An honor to present Nure Combo trial at ASCO GU24

Chiara Mercinelli, Fellow Research Oncology Resident IRCCS San Raffaele, posted on X/Twitter:

“It has been an honor to present today Nure Combo trial at ASCO GU24. Great results with neoadjuvant nivolumab/abraxane followed by adjuvant nivolumab in MIBC, with 38.7% ypT0N0.”

Image

Source: Chiara Mercinelli/X

 

ASCO bladder cancer cancer Chiara Mercinelli GU24 muscle invasive bladder cancer nivolumab/abraxane Nure Combo OncoDaily Oncology
Blog
Aug 10, 2024, 15:07
The 2024 Damon Runyon Clinical Investigators
Career
Aug 10, 2024, 14:59
Merry Jennifer Markham: Change is essential for innovation, it's time for that change
Blog
Aug 10, 2024, 14:45
Stakeholder forum on the EU Health Policy Platform by CCI4EU
Insight
Aug 10, 2024, 14:40
Brian Shields: What can AI do now that was not possible 6 months ago?
Insight
Aug 10, 2024, 14:38
Myeloma Paper of the Day, August 10th, suggested by Robert Orlowski
Blog
Aug 10, 2024, 14:35
Tedros Adhanom Ghebreyesus: Like the Olympic flame, let peace shine bright
Insight
Aug 10, 2024, 14:33
Importance of early genetic testing for prostate cancer patients
Blog
Aug 10, 2024, 14:29
Laura Bukavina: Rishi Sekar on community-level social drivers and the lack of clinical trial availability
Blog
Aug 10, 2024, 14:26
CATALYST Summer Training program 2024 Poster Symposium
Blog
Aug 10, 2024, 14:21
Leadership Position as Director of Neurooncology at the Rutgers Cancer Institute
Insight
Aug 10, 2024, 14:02
Veronica Coppini: Our latest publication disparities in Central and Eastern European countries
Insight
Aug 10, 2024, 13:59
New hope in treating advanced grade 3 Neuroendocrine Neoplasms - Garcia-Carbonero's Lab